Truist Cuts Price Target on Inspire Medical Systems to $217 From $280, Maintains Buy Rating
Inspire Medical Systems Analyst Ratings
Morgan Stanley Cuts Price Target on Inspire Medical Systems to $210 From $250, Keeps Overweight Rating
Inspire Medical Systems Analyst Ratings
RBC Cuts Price Target on Inspire Medical Systems to $260 From $285, Maintains Outperform Rating
Inspire Medical Systems Analyst Ratings
Inspire Medical Systems (INSP) Gets a Hold From Oppenheimer
Analysts' Top Healthcare Picks: Inspire Medical Systems (INSP), Cencora (COR)
Buy Rating Affirmed for Inspire Medical Systems Amid Robust Overseas Sales and Upbeat Full-Year Guidance
Inspire Medical Systems: Strong Growth and Positive Outlook Justify a Buy Rating
Analysts Offer Insights on Healthcare Companies: Alphatec Holdings (ATEC), Aquestive Therapeutics (AQST) and Inspire Medical Systems (INSP)
Piper Sandler Maintains Overweight on Inspire Medical Systems, Raises Price Target to $255
Inspire Medical Systems Analyst Ratings
Piper Sandler Sticks to Its Buy Rating for Inspire Medical Systems (INSP)
RBC Capital Reaffirms Their Buy Rating on Inspire Medical Systems (INSP)
Inspire Medical Systems: Hold Rating Amidst Slowing Growth and Profitability Concerns
KeyBanc Sticks to Their Buy Rating for Inspire Medical Systems (INSP)
Analysts Have Conflicting Sentiments on These Healthcare Companies: Inspire Medical Systems (INSP) and AdaptHealth (AHCO)
Inspire Medical Systems Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Diamedica Therapeutics (DMAC), Inspire Medical Systems (INSP) and Maravai Lifesciences Holdings (MRVI)